Compare MIRM & NVEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MIRM | NVEC |
|---|---|---|
| Founded | 2018 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 328.9M |
| IPO Year | 2019 | 1996 |
| Metric | MIRM | NVEC |
|---|---|---|
| Price | $65.05 | $70.55 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $87.55 | N/A |
| AVG Volume (30 Days) | ★ 560.0K | 50.7K |
| Earning Date | 11-04-2025 | 01-21-2026 |
| Dividend Yield | N/A | ★ 5.66% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.85 |
| Revenue | ★ $471,794,000.00 | $24,784,396.00 |
| Revenue This Year | $53.78 | N/A |
| Revenue Next Year | $19.91 | N/A |
| P/E Ratio | ★ N/A | $24.79 |
| Revenue Growth | ★ 53.66 | N/A |
| 52 Week Low | $36.88 | $51.50 |
| 52 Week High | $78.55 | $88.50 |
| Indicator | MIRM | NVEC |
|---|---|---|
| Relative Strength Index (RSI) | 36.47 | 61.79 |
| Support Level | $63.66 | $62.71 |
| Resistance Level | $66.77 | $66.26 |
| Average True Range (ATR) | 2.99 | 2.16 |
| MACD | -0.66 | 1.25 |
| Stochastic Oscillator | 13.68 | 77.96 |
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
NVE Corp develops and sells devices that use spintronics, a nanotechnology that relies on electron spin. It manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. The company's products include Digital sensors, Medical sensors, Rotation Sensors, GT Sensors, Angle Sensors, Analog sensors, MSOP Isolators, Passive-In Transceivers, and others. The company manufactures high-performance spintronic products including sensors and couplers. The company's designs are based on giant magnetoresistance GMR and tunneling magnetoresistance TMR combined with integrated circuitry.